These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

945 related items for PubMed ID: 27777066

  • 1. Psoralen loaded liposomal nanocarriers for improved skin penetration and efficacy of topical PUVA in psoriasis.
    Doppalapudi S, Jain A, Chopra DK, Khan W.
    Eur J Pharm Sci; 2017 Jan 01; 96():515-529. PubMed ID: 27777066
    [Abstract] [Full Text] [Related]

  • 2. Preparation, characterization, and in vivo evaluation of cyclosporine cationic liposomes for the treatment of psoriasis.
    Walunj M, Doppalapudi S, Bulbake U, Khan W.
    J Liposome Res; 2020 Mar 01; 30(1):68-79. PubMed ID: 30897993
    [Abstract] [Full Text] [Related]

  • 3. Comparison of ethosomes and liposomes for skin delivery of psoralen for psoriasis therapy.
    Zhang YT, Shen LN, Wu ZH, Zhao JH, Feng NP.
    Int J Pharm; 2014 Aug 25; 471(1-2):449-52. PubMed ID: 24907596
    [Abstract] [Full Text] [Related]

  • 4. Development and in vitro assessment of psoralen and resveratrol co-loaded ultradeformable liposomes for the treatment of vitiligo.
    Doppalapudi S, Mahira S, Khan W.
    J Photochem Photobiol B; 2017 Sep 25; 174():44-57. PubMed ID: 28753523
    [Abstract] [Full Text] [Related]

  • 5. Dithranol-loaded nanostructured lipid carrier-based gel ameliorate psoriasis in imiquimod-induced mice psoriatic plaque model.
    Sathe P, Saka R, Kommineni N, Raza K, Khan W.
    Drug Dev Ind Pharm; 2019 May 25; 45(5):826-838. PubMed ID: 30764674
    [Abstract] [Full Text] [Related]

  • 6. Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC).
    Fang JY, Fang CL, Liu CH, Su YH.
    Eur J Pharm Biopharm; 2008 Oct 25; 70(2):633-40. PubMed ID: 18577447
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of psoralen ethosomes for topical delivery in rats by using in vivo microdialysis.
    Zhang YT, Shen LN, Zhao JH, Feng NP.
    Int J Nanomedicine; 2014 Oct 25; 9():669-78. PubMed ID: 24489470
    [Abstract] [Full Text] [Related]

  • 8. Comparative assessment of efficacy and safety potential of multifarious lipid based Tacrolimus loaded nanoformulations.
    Jain S, Addan R, Kushwah V, Harde H, Mahajan RR.
    Int J Pharm; 2019 May 01; 562():96-104. PubMed ID: 30902706
    [Abstract] [Full Text] [Related]

  • 9. The active compounds derived from Psoralea corylifolia for photochemotherapy against psoriasis-like lesions: The relationship between structure and percutaneous absorption.
    Alalaiwe A, Hung CF, Leu YL, Tahara K, Chen HH, Hu KY, Fang JY.
    Eur J Pharm Sci; 2018 Nov 01; 124():114-126. PubMed ID: 30153523
    [Abstract] [Full Text] [Related]

  • 10. A new psoralen-containing gel for topical PUVA therapy: development, and treatment results in patients with palmoplantar and plaque-type psoriasis, and hyperkeratotic eczema.
    De Rie MA, Van Eendenburg JP, Versnick AC, Stolk LM, Bos JD, Westerhof W.
    Br J Dermatol; 1995 Jun 01; 132(6):964-9. PubMed ID: 7662576
    [Abstract] [Full Text] [Related]

  • 11. A new topical formulation for psoriasis: development of methotrexate-loaded nanostructured lipid carriers.
    Pinto MF, Moura CC, Nunes C, Segundo MA, Costa Lima SA, Reis S.
    Int J Pharm; 2014 Dec 30; 477(1-2):519-26. PubMed ID: 25445970
    [Abstract] [Full Text] [Related]

  • 12. Polymeric micelle nanocarriers for the cutaneous delivery of tacrolimus: a targeted approach for the treatment of psoriasis.
    Lapteva M, Mondon K, Möller M, Gurny R, Kalia YN.
    Mol Pharm; 2014 Sep 02; 11(9):2989-3001. PubMed ID: 25057896
    [Abstract] [Full Text] [Related]

  • 13. Enhanced topical penetration, system exposure and anti-psoriasis activity of two particle-sized, curcumin-loaded PLGA nanoparticles in hydrogel.
    Sun L, Liu Z, Wang L, Cun D, Tong HHY, Yan R, Chen X, Wang R, Zheng Y.
    J Control Release; 2017 May 28; 254():44-54. PubMed ID: 28344018
    [Abstract] [Full Text] [Related]

  • 14. Flexible liposomal gel dual-loaded with all-trans retinoic acid and betamethasone for enhanced therapeutic efficiency of psoriasis.
    Wang W, Shu GF, Lu KJ, Xu XL, Sun MC, Qi J, Huang QL, Tan WQ, Du YZ.
    J Nanobiotechnology; 2020 May 24; 18(1):80. PubMed ID: 32448273
    [Abstract] [Full Text] [Related]

  • 15. In Vivo Microdialysis for Dynamic Monitoring of the Effectiveness of Nano-liposomes as Vehicles for Topical Psoralen Application.
    Zhang H, Zhang K, Li Z, Zhao J, Zhang Y, Feng N.
    Biol Pharm Bull; 2017 May 24; 40(11):1996-2000. PubMed ID: 29093350
    [Abstract] [Full Text] [Related]

  • 16. Efficacy study of vesicular gel containing methotrexate and menthol combination on parakeratotic rat skin model.
    Nagle A, Goyal AK, Kesarla R, Murthy RR.
    J Liposome Res; 2011 Jun 24; 21(2):134-40. PubMed ID: 20557280
    [Abstract] [Full Text] [Related]

  • 17. Comparative anti-psoriatic efficacy studies of clobetasol loaded chitin nanogel and marketed cream.
    Panonnummal R, Jayakumar R, Sabitha M.
    Eur J Pharm Sci; 2017 Jan 01; 96():193-206. PubMed ID: 27615594
    [Abstract] [Full Text] [Related]

  • 18. Skin-penetrating polymeric nanoparticles incorporated in silk fibroin hydrogel for topical delivery of curcumin to improve its therapeutic effect on psoriasis mouse model.
    Mao KL, Fan ZL, Yuan JD, Chen PP, Yang JJ, Xu J, ZhuGe DL, Jin BH, Zhu QY, Shen BX, Sohawon Y, Zhao YZ, Xu HL.
    Colloids Surf B Biointerfaces; 2017 Dec 01; 160():704-714. PubMed ID: 29035818
    [Abstract] [Full Text] [Related]

  • 19. CD44 Assists the Topical Anti-Psoriatic Efficacy of Curcumin-Loaded Hyaluronan-Modified Ethosomes: A New Strategy for Clustering Drug in Inflammatory Skin.
    Zhang Y, Xia Q, Li Y, He Z, Li Z, Guo T, Wu Z, Feng N.
    Theranostics; 2019 Dec 01; 9(1):48-64. PubMed ID: 30662553
    [Abstract] [Full Text] [Related]

  • 20. Microemulsions mediated effective delivery of methotrexate hydrogel: more than a tour de force in psoriasis therapeutics.
    Amarji B, Garg NK, Singh B, Katare OP.
    J Drug Target; 2016 Dec 01; 24(2):147-60. PubMed ID: 26204326
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 48.